Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development
1.Geber, W. F. & Schramm, L. C. Effect of marihuana extract on fetal hamsters and rabbits. Toxicol. Appl. Pharmacol. 14, 276–282 (1969).CAS
PubMed
Article
Google Scholar
2.Geber, W. F. & Schramm, L. C. Teratogenicity of marihuana extract as influenced by plant origin and seasonal variation. Arch. Int. Pharmacodyn. Ther. 177, 224–230 (1969).CAS
PubMed
Google Scholar
3.Graham, J. D. P. Cannabis and health. In Cannabis and Health Vol. 1 (ed. Graham, J. D. P.) 271–320 (Academic Press, 1976).
Google Scholar
4.Reece, A. S. & Hulse, G. K. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat. Res. 789, 15–25 (2016).CAS
PubMed
Article
Google Scholar
5.Zimmerman, A. M., Zimmerman, S. & Raj, A. Y. Effects of Cannabinoids on spermatogenesis in mice. In Marihuana and Medicine (eds Nahas, G. G. et al.) 347–358 (Humana Press, 1999).Chapter
Google Scholar
6.Morishima, A. Effects of cannabis and natural cannabinoids on chromosomes and ova. NIDA Res. Monogr. 44, 25–45 (1984).CAS
PubMed
Google Scholar
7.Henrich, R. T., Nogawa, T. & Morishima, A. In vitro induction of segregational errors of chromosomes by natural cannabinoids in normal human lymphocytes. Environ. Mutagen 2, 139–147 (1980).CAS
PubMed
Article
Google Scholar
8.Reece, A. S. & Hulse, G. K. Cannabis teratology explains current patterns of coloradan congenital defects: The contribution of increased cannabinoid exposure to rising teratological trends. Clin. Pediatr. 58, 1085–1123 (2019).Article
Google Scholar
9.Reece, A. S. & Hulse, G. K. Impacts of cannabinoid epigenetics on human development: Reflections on Murphy et al.’ cannabinoid exposure and altered DNA methylation in rat and human sperm’ epigenetics 2018. Epigenetics 14, 1041–1056 (2019).PubMed
PubMed Central
Article
Google Scholar
10.Reece, A. S. & Hulse, G. K. Canadian cannabis consumption and patterns of congenital anomalies: An ecological geospatial analysis. J. Addict. Med. 14, e195–e210 (2020).PubMed
PubMed Central
Article
Google Scholar
11.Reece, A. S., Wang, W. & Hulse, G. K. Pathways from epigenomics and glycobiology towards novel biomarkers of addiction and its radical cure. Med. Hypotheses 116, 10–21 (2018).CAS
PubMed
Article
Google Scholar
12.Reece, A. S. & Hulse, G. K. Rapid Response to Lane. Re: Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: A longitudinal study, 2016. BMJ Open 6, e011891–e011902 (2020).Article
Google Scholar
13.McClean, D. K. & Zimmerman, A. M. Action of delta 9-tetrahydrocannabinol on cell division and macromolecular synthesis in division-synchronized protozoa. Pharmacology 14, 307–321 (1976).CAS
PubMed
Article
Google Scholar
14.Tahir, S. K. & Zimmerman, A. M. Influence of marihuana on cellular structures and biochemical activities. Pharmacol. Biochem. Behav. 40, 617–623 (1991).CAS
PubMed
Article
Google Scholar
15.Wilson, R. G. Jr., Tahir, S. K., Mechoulam, R., Zimmerman, S. & Zimmerman, A. M. Cannabinoid enantiomer action on the cytoarchitecture. Cell. Biol. Int. 20, 147–157 (1996).CAS
PubMed
Article
Google Scholar
16.Wang, J., Yuan, W. & Li, M. D. Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: A review of proteomics analyses. Mol. Neurobiol. 44, 269–286 (2011).CAS
PubMed
Article
Google Scholar
17.Mon, M. J., Haas, A. E., Stein, J. L. & Stein, G. S. Influence of psychoactive and nonpsychoactive cannabinoids on chromatin structure and function in human cells. Biochem. Pharmacol. 30, 45–58 (1981).CAS
PubMed
Article
Google Scholar
18.Mon, M. J., Haas, A. E., Stein, J. L. & Stein, G. S. Influence of psychoactive and nonpsychoactive cannabinoids on cell proliferation and macromolecular biosynthesis in human cells. Biochem. Pharmacol. 30, 31–43 (1981).CAS
PubMed
Article
Google Scholar
19.DiNieri, J. A. et al. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol. Psychiatry 70, 763–769 (2011).CAS
PubMed
PubMed Central
Article
Google Scholar
20.Szutorisz, H. et al. Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology 39, 1315–1323 (2014).CAS
PubMed
PubMed Central
Article
Google Scholar
21.Szutorisz, H., Egervari, G., Sperry, J., Carter, J. M. & Hurd, Y. L. Cross-generational THC exposure alters the developmental sensitivity of ventral and dorsal striatal gene expression in male and female offspring. Neurotoxicol. Teratol. 58, 107–114 (2016).CAS
PubMed
PubMed Central
Article
Google Scholar
22.Szutorisz, H. & Hurd, Y. L. Epigenetic effects of cannabis exposure. Biol. Psychiatry 79, 586–594 (2016).CAS
PubMed
Article
Google Scholar
23.Watson, C. T. et al. Genome-wide DNA methylation profiling reveals epigenetic changes in the rat nucleus accumbens associated with cross-generational effects of adolescent THC exposure. Neuropsychopharmacology 40, 2993–3005 (2015).CAS
PubMed
PubMed Central
Article
Google Scholar
24.Murphy, S. K. et al. Cannabinoid exposure and altered DNA methylation in rat and human sperm. Epigenetics 13, 1208–1212 (2018).PubMed
PubMed Central
Article
Google Scholar
25.Schrott, R. et al. Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm. Epigenetics 15, 161–173 (2019).PubMed
PubMed Central
Article
Google Scholar
26.Vela, G. et al. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Res. 807, 101–109 (1998).CAS
PubMed
Article
Google Scholar
27.Fish, E. W. et al. Cannabinoids exacerbate alcohol teratogenesis by a CB1-hedgehog interaction. Sci. Rep. 9, 16057 (2019).ADS
PubMed
PubMed Central
Article
CAS
Google Scholar
28.Callén, L. et al. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. J. Biol. Chem. 287, 20851–20865 (2012).PubMed
PubMed Central
Article
CAS
Google Scholar
29.Rozenfeld, R. et al. Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. PLoS ONE 7, e29239 (2012).ADS
CAS
PubMed
PubMed Central
Article
Google Scholar
30.Schoffelmeer, A. N., Hogenboom, F., Wardeh, G. & De Vries, T. J. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Neuropharmacology 51, 773–781 (2006).CAS
PubMed
Article
PubMed Central
Google Scholar
31.Rozenfeld, R. et al. AT1R-CB1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. EMBO J. 30, 2350–2363 (2011).CAS
PubMed
PubMed Central
Article
Google Scholar
32.Viñals, X. et al. Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors. PLoS Biol. 13, e1002194 (2015).PubMed
PubMed Central
Article
CAS
Google Scholar
33.Kargl, J. et al. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55. J. Biol. Chem. 287, 44234–44248 (2012).CAS
PubMed
PubMed Central
Article
Google Scholar
34.Ellis, J., Pediani, J. D., Canals, M., Milasta, S. & Milligan, G. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. J. Biol. Chem. 281, 38812–38824 (2006).CAS
PubMed
Article
Google Scholar
35.Kearn, C. S., Blake-Palmer, K., Daniel, E., Mackie, K. & Glass, M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?. Mol. Pharmacol. 67, 1697–1704 (2005).CAS
PubMed
Article
Google Scholar
36.Carriba, P. et al. Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32, 2249–2259 (2007).CAS
PubMed
Article
Google Scholar
37.Forrester, M. B. & Merz, R. D. Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986–2002. J. Toxicol. Environ. Health 70, 7–18 (2007).CAS
Article
Google Scholar
38.Reece, A.S. & Hulse, G.K. Broad spectrum epidemiological contribution of cannabis and other substances to the teratological profile of Northern New South Wales: Geospatial and causal inference analysis. BMC Pharmacol. Toxicol. 21(1), 75 (2020).39.Reece, A.S. & Hulse, G.K. Cannabis in pregnancy: Rejoinder, exposition and cautionary tales. Psychiatric Times. https://www.bing.com/search?q=Cannabis+in+Pregnancy+%E2%80%93+Rejoinder%82C+Exposition+and+Cautionary+Tales&cvid=22538e20124c04711b92017489c92063214a&aqs=edge..92017469i92017457.92017439j92017480j92017481&pglt=92017443&FORM=ANSPA92017481&PC=U92017531 (2020).40.Cheng, L. et al. Testicular cancer. Nat. Rev. Dis. Primers 4, 29 (2018).PubMed
Article
PubMed Central
Google Scholar
41.Oosterhuis, J. W. & Looijenga, L. H. J. Germ cell tumors from a developmental perspective: Cells of origin, pathogenesis, and molecular biology (emerging patterns). In Pathology and Biology of Human Germ Cell Tumors (eds Nogales, F. F. & Jimenez, R. E.) 23–129 (Springer, 2017).Chapter
Google Scholar
42.Shen, H. et al. Integrated molecular characterization of testicular germ cell tumors. Cell. Rep. 23, 3392–3406 (2018).CAS
PubMed
PubMed Central
Article
Google Scholar
43.Daling, J. R. et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 115, 1215–1223 (2009).PubMed
Article
PubMed Central
Google Scholar
44.Callaghan, R. C., Allebeck, P., Akre, O., McGlynn, K. A. & Sidorchuk, A. Cannabis use and incidence of testicular cancer: A 42-year follow-up of Swedish men between 1970 and 2011. Cancer Epidemiol. Biomarkers Prev. 26, 1644–1652 (2017).CAS
PubMed
PubMed Central
Article
Google Scholar
45.Trabert, B., Sigurdson, A. J., Sweeney, A. M., Strom, S. S. & McGlynn, K. A. Marijuana use and testicular germ cell tumors. Cancer 117, 848–853 (2011).PubMed
Article
PubMed Central
Google Scholar
46.Lacson, J. C. et al. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer 118, 5374–5383 (2012).CAS
PubMed
Article
PubMed Central
Google Scholar
47.Volkow, N. D., Compton, W. M. & Wargo, E. M. The risks of marijuana use during pregnancy. JAMA 317, 129–130 (2017).PubMed
Article
PubMed Central
Google Scholar
48.Volkow, N. D., Han, B., Compton, W. M. & Blanco, C. Marijuana use during stages of pregnancy in the United States. Ann. Intern. Med. 166, 763–764 (2017).PubMed
PubMed Central
Article
Google Scholar
49.Efird, J. T. et al. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: Cigarette smoking and other lifestyle behaviors. J. Neurooncol. 68, 57–69 (2004).PubMed
Article
PubMed Central
Google Scholar
50.Grufferman, S., Schwartz, A. G., Ruymann, F. B. & Maurer, H. M. Parents’ use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control 4, 217–224 (1993).CAS
PubMed
Google Scholar
51.Kuijten, R. R., Bunin, G. R., Nass, C. C. & Meadows, A. T. Gestational and familial risk factors for childhood astrocytoma: Results of a case-control study. Cancer Res. 50, 2608–2612 (1990).CAS
PubMed
Google Scholar
52.Reece, A. S. & Hulse, G. K. A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates. BMC Cancer 21, 197 (2021).CAS
PubMed
PubMed Central
Article
Google Scholar
53.Grobner, S. N. et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321–327 (2018).ADS
PubMed
Article
CAS
PubMed Central
Google Scholar
54.Ma, X. et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature 555, 371–376 (2018).ADS
CAS
PubMed
PubMed Central
Article
Google Scholar
55.McCantz-Katz, E. 2017 Annual Report Snippets, NSDUH, SAMHSA, USA DHHS: Selected streamlined trends. Vol. 1 (ed. Substance Abuse and Mental Health Services Administration US Department of Health and Human Services) 1–78 (SAMHSA, DHHS, 2018).56.McCantz-Katz, E. The National Survey of Drug Use and Health: 2019. Vol. 1 (eds. Substance Abuse and Mental Health Services Administration & US Department of Health and Human Services) 1–63 (SAMHSA, US DHHS, 2020).57.Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS) & United States of America. National Survey on Drug Use and Health. Vol. 2018 (Department of Health and Human Services, 2018).58.United National Office of Drugs and Crime. World Drug Report 2019. Vol. 1–5 (ed. World Health Organization Office of Drugs and Crime) https://wdr.unodc.org/wdr2019/index.html (United National World Health Organization, 2019).59.Busch, F. W., Seid, D. A. & Wei, E. T. Mutagenic activity of marihuana smoke condensates. Cancer Lett. 6, 319–324 (1979).CAS
PubMed
Article
PubMed Central
Google Scholar
60.Zimmerman, A. M. & Raj, A. Y. Influence of cannabinoids on somatic cells in vivo. Pharmacology 21, 277–287 (1980).CAS
PubMed
Article
Google Scholar
61.Tahir, S. K., Trogadis, J. E., Stevens, J. K. & Zimmerman, A. M. Cytoskeletal organization following cannabinoid treatment in undifferentiated and differentiated PC12 cells. Biochem. Cell Biol. 70, 1159–1173 (1992).CAS
PubMed
Article
Google Scholar
62.United States Department of Health and Human Services, Centers for Disease Control and Prevention and & National Cancer Institute. National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: NPCR and SEER Incidence: U.S. Cancer Statistics Public Use Research Database, 2019 submission (2001–2017), United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Released June 2020. www.cdc.gov/cancer/public-use. Vol. 2020 (ed. United States Department of Health and Human Services, C.f.D.C.a.P.a.N.C.I.) (United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2020).63.National Birth Defects Prevention Network. National Birth Defects Prevention Network. Vol. 2018 (ed. Network, N.B.D.P.) (National Birth Defects Prevention Network, 2018).64.Abeywardana, S. & Sullivan, E. A. Congenital Anomalies in Australia 2002–2003 (Australian Institute of Health and Welfare, 2008).
Google Scholar
65.Bird, T. M., Hobbs, C. A., Cleves, M. A., Tilford, J. M. & Robbins, J. M. National rates of birth defects among hospitalized newborns. Birth. Defects Res. A 76, 762–769 (2006).CAS
Article
Google Scholar
66.Natoli, J. L., Ackerman, D. L., McDermott, S. & Edwards, J. G. Prenatal diagnosis of Down syndrome: A systematic review of termination rates (1995–2011). Prenat. Diagn. 32, 142–153 (2012).PubMed
Article
Google Scholar
67.Substance Abuse and Mental Health Network. Substance Abuse and Mental Health Data Archive (SAMHDA). Vol. 2019 (ed. Substance Abuse and Mental Health Services Administration) (Substance Abuse and Mental Health Services Administration, Substance Abuse and Mental Health Services Administration, 2019).68.ElSohly, M. A. et al. Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biol. Psychiatry 79, 613–619 (2016).CAS
PubMed
PubMed Central
Article
Google Scholar
69.Chandra, S. et al. New trends in cannabis potency in USA and Europe during the last decade (2008–2017). Eur. Arch. Psychiatry Clin. Neurosci. 269, 5–15 (2019).PubMed
Article
Google Scholar
70.ElSohly, M. A. et al. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980–1997. J. Forensic Sci. 45, 24–30 (2000).CAS
PubMed
Article
Google Scholar
71.VanderWeele, T. J., Ding, P. & Mathur, M. Technical considerations in the use of the e-value. J. Causal Inference 7, 1–11 (2019).Article
Google Scholar
72.Pearl, J. & Mackaenzie, D. The Book of Why (Basic Books, 2019).
Google Scholar
73.Sarafian, T. A., Kouyoumjian, S., Khoshaghideh, F., Tashkin, D. P. & Roth, M. D. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am. J. Physiol. 284, L298-306 (2003).CAS
Google Scholar
74.Sarafian, T. A. et al. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. Am. J. Physiol. 290, L1202-1209 (2006).CAS
Google Scholar
75.Morimoto, S. et al. Identification and characterization of cannabinoids that induce cell death through mitochondrial permeability transition in Cannabis leaf cells. J. Biol. Chem. 282, 20739–20751 (2007).CAS
PubMed
Article
Google Scholar
76.Shoyama, Y., Sugawa, C., Tanaka, H. & Morimoto, S. Cannabinoids act as necrosis-inducing factors in Cannabis sativa. Plant Signal Behav. 3, 1111–1112 (2008).PubMed
PubMed Central
Article
Google Scholar
77.Fisar, Z., Singh, N. & Hroudova, J. Cannabinoid-induced changes in respiration of brain mitochondria. Toxicol. Lett. 231, 62–71 (2014).CAS
PubMed
Article
Google Scholar
78.Koller, V. J. et al. Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497–C8. Toxicol. Appl. Pharmacol. 277, 164–171 (2014).CAS
PubMed
Article
Google Scholar
79.Koller, V. J. et al. Genotoxic properties of representatives of alkylindazoles and aminoalkyl-indoles which are consumed as synthetic cannabinoids. Food Chem. Toxicol. 80, 130–136 (2015).CAS
PubMed
Article
Google Scholar
80.Singh, N., Hroudova, J. & Fisar, Z. Cannabinoid-induced changes in the activity of electron transport chain complexes of brain mitochondria. J. Mol. Neurosci. 56, 926–931 (2015).CAS
PubMed
Article
Google Scholar
81.Russo, C. et al. Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells. Arch. Toxicol. 93, 1–195 (2018).
Google Scholar
82.Reece, A. S. & Hulse, G. K. Broad Spectrum epidemiological contribution of cannabis and other substances to the teratological profile of northern New South Wales: geospatial and causal inference analysis. BMC Pharmacol. Toxicol. 21, 75 (2020).CAS
PubMed
PubMed Central
Article
Google Scholar
83.Reece, A. S. & Hulse, G. K. Cannabis consumption patterns explain the east-west gradient in Canadian Neural Tube Defect Incidence: An ecological study. Glob. Pediatr. Health 6, 2333 (2019).
Google Scholar
84.Gurney, J., Shaw, C., Stanley, J., Signal, V. & Sarfati, D. Cannabis exposure and risk of testicular cancer: A systematic review and meta-analysis. BMC Cancer 15, 897 (2015).CAS
PubMed
PubMed Central
Article
Google Scholar
85.Song, A. et al. Incident testicular cancer in relation to using marijuana and smoking tobacco: A systematic review and meta-analysis of epidemiologic studies. Urol. Oncol. 38(642), e641-642 (2020).
Google Scholar
86.Torchiano M. effzise: Efficient Effect Size Computation. Vol. 2020 (CRAN, 2020). https://CRAN.R-project.org/package=effsize.87.Agence France-Presse in Paris. France to investigate cause of upper limb defects in babies. In The Guardian (The Guardian, London, 2018).88.Robinson M. Babies born with deformed hands spark investigation in Germany. Vol. 2019 (ed. Health, C.) (CNN News, 2019). https://edition.cnn.com/2019/09/16/health/hand-deformities-babies-gelsenkirchen-germany-intl-scli-grm/index.html.89.Robison, L. L. et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring: An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer 63, 1904–1911 (1989).CAS
PubMed
Article
Google Scholar
90.Wen, W. Q. et al. Paternal military service and risk for childhood leukemia in offspring. Am. J. Epidemiol. 151, 231–240 (2000).CAS
PubMed
Article
Google Scholar
91.Society, A.C. Cancer Facts & Figures 2020 Vol. 2020 (American Cancer Society, 2020).
Google Scholar
92.Patsenker, E. & Stickel, F. Cannabinoids in liver diseases. Clin. Liver Dis. 7, 21–25 (2016).Article
Google Scholar
93.Yang, Y. Y. et al. Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis. Clin. Sci. 112, 533–542 (2007).CAS
Article
Google Scholar
94.Mukhopadhyay, B. et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology 61, 1615–1626 (2015).CAS
PubMed
Article
Google Scholar
95.Zimmerman, A. M., Zimmerman, S. & Raj, A. Y. Effects of cannabinoids on spermatogensis in mice. In Marijuana and Medicine Vol. 1 (eds Nahas, G. G. et al.) 347–358 (Humana Press, 1999).
Google Scholar
96.Huang, H. F. S., Nahas, G. G. & Hembree, W. C. Effects of marijuana inhalantion on spermatogenesis of the rat. In Marijuana in Medicine Vol. 1 (eds Nahas, G. G. et al.) 359–366 (Human Press, 1999).
Google Scholar
97.Russo, C. et al. Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells. Arch. Toxicol. 93, 179–188 (2019).CAS
PubMed
Article
Google Scholar
98.Szutorisz, H. & Hurd, Y. L. High times for cannabis: Epigenetic imprint and its legacy on brain and behavior. Neurosci. Biobehav. Rev. 85, 93–101 (2018).CAS
PubMed
Article
Google Scholar
99.Mon, M. J., Jansing, R. L., Doggett, S., Stein, J. L. & Stein, G. S. Influence of delta9-tetrahydrocannabinol on cell proliferation and macromolecular biosynthesis in human cells. Biochem. Pharmacol. 27, 1759–1765 (1978).CAS
PubMed
Article
Google Scholar
100.Zimmerman, A. M. & Zimmerman, S. Cytogenetic studies of cannabinoid effects. In Genetic and Perinatal Effects of Abused Substances Vol. 1 (eds Braude, M. C. & Zimmerman, A. M.) 95–112 (Academic Press Inc, 1987).
Google Scholar
101.Zimmerman, A. M., Stich, H. & San, R. Nonmutagenic action of cannabinoids in vitro. Pharmacology 16, 333–343 (1978).CAS
PubMed
Article
Google Scholar
102.Zimmerman, S. & Zimmerman, A. M. Genetic effects of marijuana. Int. J. Addict. 25, 19–33 (1990).PubMed
Article
Google Scholar
103.Nahas, G. G., Morishima, A. & Desoize, B. Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes. Fed. Proc. 36, 1748–1752 (1977).CAS
PubMed
Google Scholar
104.Blevins, R. D. & Regan, J. D. delta-9-Tetrahydrocannabinol: Effect on macromolecular synthesis in human and other mammalian cells. Arch. Toxicol. 35, 127–135 (1976).CAS
PubMed
Article
Google Scholar
105.Gadadhar, S. et al. Tubulin glycylation controls axonemal dynein activity, flagellar beat, and male fertility. Science 371, 4916 (2021).Article
CAS
Google Scholar
106.Alberts, B. et al. (eds) Molecular Biology of the Cell, 1601 (Garland Science, 2008).
Google Scholar
107.Zhang, C. Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179–184 (2015).ADS
CAS
PubMed
PubMed Central
Article
Google Scholar
108.Kloosterman, W. P. Genetics: Making heads or tails of shattered chromosomes. Science 348, 1205–1206 (2015).ADS
CAS
PubMed
Article
Google Scholar
109.de Pagter, M. S. et al. Chromothripsis in healthy individuals affects multiple protein-coding genes and can result in severe congenital abnormalities in offspring. Am. J. Hum. Genet. 96, 651–656 (2015).PubMed
PubMed Central
Article
CAS
Google Scholar
110.Kloosterman, W. P. et al. Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum. Mol. Genet. 20, 1916–1924 (2011).CAS
PubMed
Article
Google Scholar
111.Kuznetsova, A. Y. et al. Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells. Cell Cycle 14, 2810–2820 (2015).CAS
PubMed
PubMed Central
Article
Google Scholar
112.Hatch, E. M. & Hetzer, M. W. Linking micronuclei to chromosome fragmentation. Cell 161, 1502–1504 (2015).CAS
PubMed
Article
Google Scholar
113.Lusk, C. P. & King, M. C. Rotten to the core: Why micronuclei rupture. Dev. Cell 47, 265–266 (2018).CAS
PubMed
Article
Google Scholar
114.Terzoudi, G. I. et al. Stress induced by premature chromatin condensation triggers chromosome shattering and chromothripsis at DNA sites still replicating in micronuclei or multinucleate cells when primary nuclei enter mitosis. Mutat. Res. Genet. Toxicol. Environ. Mutagen 793, 185–198 (2015).CAS
PubMed
Article
Google Scholar
115.Norppa, H. & Falck, G. C. What do human micronuclei contain?. Mutagenesis 18, 221–233 (2003).CAS
PubMed
Article
Google Scholar
116.Knouse, K. A. & Amon, A. Cell biology: The micronucleus gets its big break. Nature 522, 162–163 (2015).ADS
CAS
PubMed
Article
Google Scholar
117.Waldron, D. Genome stability: Chromothripsis and micronucleus formation. Nat. Rev. Genet. 16, 376–377 (2015).CAS
PubMed
Article
Google Scholar
118.Fenech, M. et al. Micronuclei as biomarkers of DNA damage, aneuploidy, inducers of chromosomal hypermutation and as sources of pro-inflammatory DNA in humans. Mutat Res 786, 108342 (2020).CAS
PubMed
Article
Google Scholar
119.Beck, D., Ben Maamar, M. & Skinner, M. K. Integration of sperm ncRNA-directed DNA methylation and DNA methylation-directed histone retention in epigenetic transgenerational inheritance. Epigenet. Chromatin 14, 1–14 (2021).Article
CAS
Google Scholar
120.Yang, Y. & Li, G. Post-translational modifications of PRC2: signals directing its activity. Epigenet. Chromatin 13, 47 (2020).CAS
Article
Google Scholar
121.Wong, M. et al. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nat. Med. 26(11), 1742–1753 (2020).122.Reece A. S. & Hulse G. K. Cannabis and pregnancy don’t mix. Mo. Med. 117(6), 530–531 (2020).123.Reece, A. S. & Hulse, G. K. Impact of lifetime opioid exposure on arterial stiffness and vascular age: Cross-sectional and longitudinal studies in men and women. BMJ Open 4, 1–19 (2014).Article
Google Scholar
124.Hill, A. B. The environment and disease: Association or causation?. Proc. R. Soc. Med. 58, 295–300 (1965).CAS
PubMed
PubMed Central
Google Scholar
125.Robins, J. M., Hernán, M. Á. & Brumback, B. Marginal structural models and causal inference in epidemiology. Epidemiology 11, 550–560 (2000).CAS
PubMed
Article
Google Scholar
126.Raad, H., Cornelius, V., Chan, S., Williamson, E. & Cro, S. An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome. BMC Med. Res. Methodol. 20, 70 (2020).PubMed
PubMed Central
Article
Google Scholar
127.Seaman, S. R. & White, I. R. Review of inverse probability weighting for dealing with missing data. Stat. Methods Med. Res. 22, 278–295 (2013).MathSciNet
PubMed
Article
Google Scholar
128.Reece, A. S. & Hulse, G. K. Effect of cannabis legalization on US autism incidence and medium term projections. Clin. Pediatr. Open Access 4, 1–17 (2019).
Google Scholar
129.Reece, A. S. & Hulse, G. K. Impacts of cannabinoid epigenetics on human development: reflections on Murphy et al. “cannabinoid exposure and altered DNA methylation in rat and human sperm” epigenetics. Epigenetics 14, 1041–1056 (2019).PubMed
PubMed Central
Article
Google Scholar
130.Reece, A. S. & Hulse, G. K. Contemporary epidemiology of rising atrial septal defect trends across USA 1991–2016: A combined ecological geospatiotemporal and causal inferential study. BMC Pediatr. 20, 539 (2020).PubMed
PubMed Central
Article
Google Scholar
131.Reece, A. S., Norman, A. & Hulse, G. K. Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: A longitudinal study. BMJ Open 6, e011891 (2016).PubMed
PubMed Central
Article
Google Scholar
132.Corsi, D. J. et al. Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Nat. Med. 26, 1536–1540 (2020).CAS
PubMed
Article
Google Scholar
133.Corsi, D. J. The potential association between prenatal cannabis use and congenital anomalies. J. Addict. Med. 14, 451–453 (2020).PubMed
Article
Google Scholar
134.Reece, A. S. & Hulse, G. K. Epidemiological associations of various substances and multiple cannabinoids with autism in USA. Clin. Pediatr. Open Access 4, 1–20 (2019).
Google Scholar
135.Brents L. Correlates and consequences of Prenatal Cannabis Exposure (PCE): Identifying and Characterizing Vulnerable Maternal Populations and Determining Outcomes in Exposed Offspring in Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis and Treatment, Vol. 1 (ed. Preedy V.R.) 160–170 (Academic Press, 2017).136.Smith, A. M., Longo, C. A., Fried, P. A., Hogan, M. J. & Cameron, I. Effects of marijuana on visuospatial working memory: An fMRI study in young adults. Psychopharmacology 210, 429–438 (2010).CAS
PubMed
Article
PubMed Central
Google Scholar
137.Smith, A. M. et al. Prenatal marijuana exposure impacts executive functioning into young adulthood: An fMRI study. Neurotoxicol. Teratol. 58, 53–59 (2016).CAS
PubMed
Article
PubMed Central
Google Scholar
138.Fine, J. D. et al. Association of prenatal cannabis exposure with psychosis proneness among children in the adolescent brain cognitive development (ABCD) study. JAMA Psychiat. 76, 762–764 (2019).Article
Google Scholar
139.Paul, S. E. et al. Associations between prenatal cannabis exposure and childhood outcomes: Results from the ABCD study. JAMA Psychiat. 78, 1–64 (2020).
Google Scholar
140.Women and Newborn Health Service, Department of Health & Government of Western Australia. Western Australian Register of Developmental Anomalies 1980–2014. Vol. 1 (ed. Western Australia Health) 28 (Western Australia Health, 2015).141.Walker, K., Herman, M. & Eberwein, K. tidycensus: Load US Census Boundary and Attribute Data as ‘tidyverse’ and ‘sf’-Ready Data Frames. Vol. 2020 (ed. Network, C.C.R.A.) (CRAN, 2020).142.Wikipedia. Legality of Cannabis by U.S. Juridicition. Vol. 2020 (Wikipedia, 2020). https://en.wikipedia.org/wiki/Legality_of_cannabis_by_U.S._jurisdiction.143.Wickham, H. et al. Welcome to the Tidyverse. J. Open Source Softw. 4, 1686–1691 (2019).ADS
Article
Google Scholar
144.Wei, T. & Simko, V. R package “corrplot”: Visualization of a Correlation Matrix. Vol. 2020 Version 0.84 (CRAN, 2017). https://github.com/taiyun/corrplot.145.Wright, K. corrgram: Plot a Correlogram. In CRAN, Vol. 2020 (ed. Network, C.C.R.A.) (CRAN, 2018). https://CRAN.R-project.org/package=corrgram.146.Kliber, C. & Zeileis, A. Applied Econometrics with R (Springer-Verlag, New York, 2008). https://CRAN.R-project.org/package=AER.147.Lumley, T. Complex Surveys: A Guide to Analysis Using R (Wiley, 2010).Book
Google Scholar
148.Revelle, W. psych: Procedures for Psychological, Psychometric, and Personality Research (Northwestern University, 2020).
Google Scholar
149.Wal, W. & Geskus, R. ipw: An R package for inverse probability weighting. J. Stat. Softw. 43, 13 (2011).Article
Google Scholar More